Literature DB >> 25400733

Increased susceptibility of sepsis associated with CD143 deletion/insertion polymorphism in Caucasians: a meta analysis.

Hongming Yang1, Yihe Wang1, Lingying Liu1, Quan Hu1.   

Abstract

BACKGROUND: Several lines of evidence have reported that serum angiotensin-converting enzyme (CD143) levels are genetically regulated by insertion/deletion (ins/del) polymorphism in intron 16 of the CD143 gene. In addition, published data on the association of ins/del polymorphism and sepsis risk yielded contradictory conclusions. Therefore, we determined to perform a meta-analysis to validate the association of much debate. Methods and major findings: Relevant literature was identified through weekly searches in databases and references of systematic reviews and the single studies incorporated in this meta-analysis. We combined ORs and its 95% CIs for several genetic models to evaluate the risk of sepsis associated with ins/del polymorphism. A total of seven studies were considered eligible for this analysis. We found significantly increased risk of sepsis in relation to the homozygote ins/ins (OR: 1.32, 95% CI: 1.04-1.68, P: 0.4201, for ins/ins vs. del/del), heterozygote del/ins (OR: 1.33, 95% CI: 1.11-1.61, P: 0.7937, for del/ins vs. del/del) and the two genotypes combined (OR: 1.33, 95% CI: 1.11-1.59, P: 0.7018, for ins/ins + del/ins vs. del/del). Subgroup analysis by age group showed a significant association in pediatric sepsis, but not in adult sepsis.
CONCLUSIONS: The statistical data suggest that the CD143 gene ins/del polymorphism may influence the risk of sepsis, especially pediatric sepsis.

Entities:  

Keywords:  CD143-ins/del polymorphism-sepsis

Mesh:

Substances:

Year:  2014        PMID: 25400733      PMCID: PMC4230104     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  41 in total

Review 1.  Crosstalk between inflammation and coagulation: the lessons of sepsis.

Authors:  Tom van der Poll; Marcel Levi
Journal:  Curr Vasc Pharmacol       Date:  2012-09       Impact factor: 2.719

2.  Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients.

Authors:  Argirios Tsantes; Iraklis Tsangaris; Petros Kopterides; Georgios Nikolopoulos; Eleni Kalamara; Georgios Antonakos; Violetta Kapsimali; Argiri Gialeraki; Ioanna Dimopoulou; Stylianos Orfanos; Kleanthi Dima; Anthi Travlou; Apostolos Armaganidis
Journal:  Clin Chem Lab Med       Date:  2011-10-21       Impact factor: 3.694

Review 3.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 4.  Genetic polymorphisms in sepsis.

Authors:  Allen Namath; Andrew J Patterson
Journal:  Crit Care Nurs Clin North Am       Date:  2011-03       Impact factor: 1.326

5.  The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis.

Authors:  Sarah M Davis; Erin A S Clark; Lesa T Nelson; Robert M Silver
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

6.  ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria.

Authors:  Vahid Felehgari; Zohreh Rahimi; Hadi Mozafari; Asad Vaisi-Raygani
Journal:  Mol Cell Biochem       Date:  2010-09-10       Impact factor: 3.396

7.  Angiotensin-converting enzyme (ACE) serum levels and gene polymorphism in Egyptian patients with systemic lupus erythematosus.

Authors:  D Abbas; Y Ezzat; E Hamdy; M Gamil
Journal:  Lupus       Date:  2011-10-05       Impact factor: 2.911

8.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

9.  Role of angiotensin-converting enzyme gene polymorphisms in children with sepsis and septic shock.

Authors:  Ozgur Cogulu; Huseyin Onay; Demet Uzunkaya; Cumhur Gunduz; Sacide Pehlivan; Fadil Vardar; Fusun Atlihan; Cihangir Ozkinay; Ferda Ozkinay
Journal:  Pediatr Int       Date:  2008-08       Impact factor: 1.524

10.  Polymorphisms in the Renin-Angiotensin system and outcome of very-low-birthweight infants.

Authors:  J Spiegler; A Gilhaus; I R Konig; E Kattner; M Vochem; H Kuster; J Moller; D Muller; A Kribs; H Segerer; C Wieg; W Nikischin; A von der Wense; C Gebauer; E Herting; W Gopel
Journal:  Neonatology       Date:  2009-07-02       Impact factor: 4.035

View more
  3 in total

1.  Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Authors:  James A Tumlin; Raghavan Murugan; Adam M Deane; Marlies Ostermann; Laurence W Busse; Kealy R Ham; Kianoush Kashani; Harold M Szerlip; John R Prowle; Azra Bihorac; Kevin W Finkel; Alexander Zarbock; Lui G Forni; Shannan J Lynch; Jeff Jensen; Stew Kroll; Lakhmir S Chawla; George F Tidmarsh; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

2.  Angiotensin converting enzyme defects in shock: implications for future therapy.

Authors:  Lakhmir S Chawla; Steve Chen; Rinaldo Bellomo; George F Tidmarsh
Journal:  Crit Care       Date:  2018-10-28       Impact factor: 9.097

3.  Genetic variants in Forkhead box O1 associated with predisposition to sepsis in a Chinese Han population.

Authors:  Huijuan Wang; Zhaohui Tong; Jia Li; Kun Xiao; Feifei Ren; Lixin Xie
Journal:  BMC Infect Dis       Date:  2019-09-06       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.